sequential different B cell antigen-targeted CAR T-cell therapy / Beijing Boren Hospital 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sequential different B cell antigen-targeted CAR T-cell therapy / Beijing Boren Hospital
ChiCTR1800014457: Phase I study of sequential B antigen chimeric antigen receptor T cells treating refractory and relapsed mature B cell Lymphoma in children and young adolescents

Recruiting
1
20
 
sequential B antigen chimeric antigen receptor T cells
Beijing Boren Hospital; Beijing Boren Hospital, research fund of Beijing BOREN hospital
lymphoma
 
 
ChiCTR1900024457: Phase I study for the safety of different B-cell target CART cells in the treatment of recurrent and refractory mature B-cell lymphoma involving maxillofacial and / or central nervous system involvement

Completed
N/A
10
 
sequential B antigen chimeric antigen receptor T cells
Beijing Boren Hospital; Beijing Boren Hospital, Beijing Boren Hospital
recurrent and refractory mature B-cell lymphoma involving maxillofacial and / or central nervous system involvement
 
 

Download Options